Press release
Unlocking Opportunities in the Osteoporosis Drugs Market: 2025-2034 Forecast Report
Osteoporosis Drugs Market Size
Osteoporosis Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for osteoporosis medications has seen a consistent increase in size in the past few years. In terms of value, it is set to rise from $12.33 billion in 2024 to $12.8 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.8%. The growth observed in the historical period is linked to factors such as an ageing population, heightened awareness and diagnostics, lifestyle influences, government-driven initiatives, and healare policies.
Osteoporosis Drugs Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the osteoporosis drugs market is projected to experience consistent growth. By 2029, it is estimated to expand to $14.48 billion, with a compound annual growth rate (CAGR) of 3.1%. The predicted growth in the forecast period can be credited to the continuous trend of an aging population, advancements in therapeutic options, heightened focus on the bone health of men, the education and empowerment of patients, and the global health policies along with insurance coverage. During the forecast period, principal trends include personalized treatment strategies, the exploration of combined therapies, emphasis on strategies for fracture prevention, research and development financing in innovative drug targets, and collaborations in drug development.
View the full report here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
What Are the Drivers Transforming the Osteoporosis Drugs Market?
The increasing occurrence of osteoporosis is predicted to boost the osteoporosis medication market's expansion. Osteoporosis is a condition affecting the bones, characterized by a decrease in bone mineral density, mass bone, or alterations in bone quality or structure. Those with a sparse intake of calcium are at a higher risk of developing this malady. Osteoporosis medications work by enhancing bone mineral density and averting fractures. As reported by the Australian Institute of Health and Welfare Australia-government agency, during June 2024, osteoporosis was behind 2,659 fatalities in 2022, which is 10.2 deaths per 100,000 population and signifies 1.4% of all deaths. Hence, the rising occurrences of osteoporosis are propelling the development of the osteoporosis drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
What Long-Term Trends Will Define the Future of the Osteoporosis Drugs Market?
Leading firms in the osteoporosis drugs market are progressing towards utilizing innovative solutions. In November 2023, for example, Apotex Inc., a pharmaceutical corporation based in Canada, unveiled the Teriparatide Injectable for Osteoporosis Treatment. The teriparatide injection is a pre-filled pen which contains 250 mcg/mL, capable of delivering twenty-eight daily doses of 20 mcg each per pen, designed for use by a single patient. This development offers these patients affordable and highly needed access.
Which Segments in the Osteoporosis Drugs Market Offer the Most Profit Potential?
The osteoporosis drugs market covered in this report is segmented -
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis
Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene
3) By RANK Ligand Inhibitors: Denosumab
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp
Which Firms Dominate the Osteoporosis Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.
Which Regions Offer the Highest Growth Potential in the Osteoporosis Drugs Market?
North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlocking Opportunities in the Osteoporosis Drugs Market: 2025-2034 Forecast Report here
News-ID: 4114252 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In Osteoporosis Treatment Market: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Osteoporosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the realm of osteoporosis treatments, the market has seen consistent expansion recently, projected to increase its valuation from $13.96 billion in 2024 to $14.57 billion come 2025, reflecting a compound annual growth rate of…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Postmenopausal Osteoporosis Treatment Market Through 2025?
Valuations for the marketplace addressing postmenopausal osteoporosis treatments have demonstrated consistent upward movement throughout the preceding years, projecting an expansion from a figure of $10.1 billion in 2024 to an anticipated $10.54 billion by 2025, reflecting…
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
